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ABSTRACT
 Disinfection by-products (DBPs) are the unintended consequence of using 
chemical disinfectants to kill pathogens in water. 1-11 They are formed from the 
reaction between disinfectants and natural organic matter (NOM), anthropogenic 
contaminants, and bromide/iodide present in the raw source water. DBPs are 
cause for concern because studies have found them to be toxic.11-16 This research 
focuses on identifying and studying the formation of DBPs. Specifically, the 
presence of DBPs in chlorinated pool water and tap water from Barcelona, Spain 
was studied to better understand which DBPs are formed in the pool as 
compared to those that enter the pool from the tap water source used to fill the 
pool. Samples from the pool and tap were analyzed using gas chromatography-
mass spectrometry (GC-MS) and approximately 100 DBPs were comprehensively 
identified. It was found that more nitrogen-containing DBPs (N-DBPs) were 
identified in the pool water than in the tap water, likely due to the increased 
nitrogenous input from swimmers in the pool (urine, sweat, skin cells, 
hair,cosmetics). Additionally, this research evaluated the role of X-ray contrast 
media (ICM) as a precursor for iodo-DBPs, by studying source waters from 
several locations that had been reacted with ICM and chlorine disinfectant. 
vi 
Several iodo-DBPs were found in the iopamidol-chlorinated waters, including 
five new iodo-DBPs not previously known:  iodoacetonitrile, 
chloroiodoacetonitrile, dichloroiodoacetic acid, bromochloroiodoacetic acid, and 
chlorodiiodoacetic acid. Gas chromatography (GC)- high resolution mass 
spectrometry (HRMS) (with electron ionization [EI]) was used to identify the 
new iodo-nitriles, and a new, sensitive GC-EI-MS/MS method was used to 
identify the new iodo-acids.  
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CHAPTER 1 
INTRODUCTION
Since the 1900s, water disinfection has played an important role in 
decreasing the prevalence of waterborne illnesses that were once a leading cause 
of death among the population.17 Disinfectants used vary by location, but include 
chlorine, chloramine, chlorine dioxide, and UV Treatment.11 While the 
disinfectants inactivate pathogens such as salmonella typhi, vibrio cholerae, 
shigella, E.coli, etc. that are responsible for diseases such as typhoid fever, 
cholera, and dysentery, the disinfection process is not without its drawbacks.11  
The strong oxidizing capacity of the disinfectants cause the death of 
microorganisms that are responsible for many diseases. 5, 12, 18-19  However, the 
strong oxidizing power is not selective, and the disinfectants will also react with 
natural organic matter (NOM), anthropogenic contaminants, and bromide/iodide 
present in the raw source water to form disinfection by-products (DBPs). 11-16 
Thus, disinfection by-products are the unintended consequence of using 
chemical disinfectants to kill pathogens in water, and have been reported to form 
with most disinfectants.1-11 
2 
DBPs are a source of concern because studies have linked them to bladder 
cancer, early term miscarriages, birth defects, asthma, and other respiratory 
ailments. 2, 4-5 Trihalomethanes (THMs) and haloacetic acids (HAAs) are two of 
the most prevalent groups of DBPs formed during disinfection.4-5, 7, 20-21 Because of 
their implications on human health, the US Environmental Protection Agency 
(USEPA) has set regulatory limits on four THMs and five HAAs.5, 10, 22 However, 
disinfection can also form many more DBPs than those that are regulated. In the 
presence of bromide and iodide in the water, chlorine can react to form not just 
chlorinated DBPs, but also brominated and iodinated-DBPs.1, 13, 23-25 Iodinated 
DBPs have been found to be more toxic than their brominated and chlorinated 
analogues and nitrogen containing DBPs (N-DBPs) have been found to be more 
toxic than their carbon-based analogues (Figures 1.1 and 1.2) 23, 26-27 
There are many factors that contribute to the formation of different DBPs, 
including concentrations of bromide/iodide in the source water, concentration 
and composition of natural organic matter, and temperature.6, 10, 22  The presence 
of DBPs in drinking water is well studied, but it is hypothesized that only a small 
percentage have been identified.2, 10-11, 22, 28 Thus, in order to get a better 
understanding on the formation of DBPs and further identify the unknowns, it is 
important to study environments that have characteristics that will likely 
3 
promote the formation of DBPs as well as investigate potential precursors of 
DBPs.  
Specifically, this research investigates the occurrence of brominated and 
chlorinated DBPs found in a chlorinated swimming pool (Chapter 2) and the role 
of iodinated X-ray contrast media (ICM) as a precursor to iodinated DBPs found 
in drinking water (Chapter 3)
4 
FIGURES 
 
Figure 1.1: Cytotoxicity and genotoxicity of carbon-based DBPS compared to nitrogen-
based DBPs.29 
 
 
Figure 1.2: Cytotoxicity and genotoxicity of halogenated DBPs.29 
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CHAPTER 2 
COMPREHENSIVE IDENTIFICATION OF DISINFECTION BY-
PRODUCTS IN POOL AND TAP WATERS FROM BARCELONA, 
SPAIN 
2.1 Introduction  
The same factors that contribute to DBP formation in drinking water also 
exist in pools. Such factors include the presence of a disinfectant, exposure to 
high temperatures, and organic input from swimmers (urine, sweat, cosmetics, 
skin cells, hair).4, 9, 16, 28, 30-43  This research has important implications because prior 
studies have shown that inhalation and dermal contact are significant routes of 
exposure to carcinogenic and irritant DBPs.3-4, 6-7, 21, 28, 41, 44-48 Some studies even 
suggest that exposure from inhalation and dermal absorption may be equivalent 
to or greater than that from ingestion.5, 44-46, 49  Biomarkers of lung epithelium 
permeability (serum CC16) and genotoxicity (micronuclei [MN] in lymphocytes) 
and urine mutagenicity were previously found to be related to brominated THM 
exposure subsequent to swimming 40 minutes in a chlorinated indoor pool. 
Another study showed that after swimming, the total concentration of four 
THMs in exhaled breath was seven times higher than before swimming.50 Given 
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the high nitrogen content of organic matter from swimmers, nitrogenated 
species, such as haloacetonitriles and haloamides, are found in pools. As 
mentioned previously, nitrogen-containing DBPs are more toxic than their 
carbon-container analogs. Studies have suggested that asthma and other 
respiratory ailments in swimmers and pool workers have a likely association 
with DBPs found in the pool.51-54 Thus, these toxic DBPs pose a threat to 
swimmers and therefore need to be identified.50, 55-56 Chapter 1 discusses research 
focused on the identification of brominated and chlorinated DBPs in both tap 
and pool water from Barcelona, Spain.  
 
2.2 Experimental Methods 
Water Sampling. Collaborators in Barcelona, Spain conducted four sampling 
campaigns on four different days (June 3, 2013 [pool/tap 1], June 11, 2013 
[pool/tap 2], November 18, 2013 [pool/tap 3], and December 9, 2013 [pool/tap 4]). 
During each sampling event, water was collected from the same pool and 
corresponding tap water in the pool facility. Two-liter Teflon bottles were used 
to collect 25 L of each (headspace free). Samples were stored at 4°C and shipped 
overnight in coolers with icepacks to the United States. Water samples were 
extracted immediately upon arrival using XAD resin extraction.57 After 
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extraction, pool and tap water samples were sent to our lab for comprehensive 
gas chromatography-mass spectrometry analysis.  
Comprehensive GC-MS Analysis. Analyses were performed using electron 
ionization (EI) on an Agilent 5975 inert XL Mass Selective Detector mass 
spectrometer equipped with an Agilent model 6890 GC and operated at an 
accelerating voltage of 8 kV and a source temperature of 200°C (Agilent 
Technologies, Santa Clara, CA). Injections of 1 µL of the extracts were introduced 
via a split/splitless injector (in pulsed splitless mode) onto a GC column (RTX-
200, 30 m X 0.25 mm i.d., 0.25 µm film thickness, Restek, Bellefonte, PA). The GC 
temperature program consisted of an initial temperature of 40°C (4 min), 
increased to 9°C/min to 280°C and held for 20 minutes, for a total run time of 
50.67 minutes. The transfer line was held at 280°C and the inlet temperature at 
250°C with an electron energy at 70 eV. Analyses were performed in full scan. 
Example chromatograms for tap 4 ad pool 4 are illustrated in Figures 2.1 and 2.2  
 
2.3 Results and Discussion 
Approximately 100 DBPs were comprehensively identified in the tap and 
pool water (Table 2.1) from Barcelona, Spain. Such classes of DBPs included 
halomethanes, haloacids, haloacetonitriles, haloaldehydes, haloketones, 
halonitromethanes, haloamides, haloalcohols, and halophenols, where either 
8 
bromine, chlorine, or both were the halogen present. No iodinated DBPs were 
detected in the tap or swimming pool waters.  
In general, the profile of identified DBPs was similar in both the tap and pool 
water samples. For example, all samples contained dibromochloromethane, 
tribromomethane, bromodichloroacetaldehyde, dibromoacetaldehyde, 
dichloroacetic acid, dibromoacetic acid, trichloroacetic acid, bromodichloroacetic 
acid, dibromochloroacetic acid, and benzaldehyde. However, there were a few 
compounds that were identified solely in the tap water samples or solely in the 
pool water samples. Several tribrominated compounds were found only in the 
tap water samples. Such compounds included tribromoacetonitrile, 
tribromoacetaldehyde, tribromoacetic acid, and 1,1,1-tribromopropanone found 
in tap 1, 3, and 4. Other compounds identified only in the tap water sample 
include 1-bromo-2-propanone, 2,2-dibromopropanoic acid, cis-2,3-
dibromobutenedioic acid, and trans-2,3-dibromobutenedioic acid. Tri-
brominated compounds are highly subject to degradation, so it is probable that 
the ones identified in the tap water degraded before entering the pool, and thus 
were not identified in the pool waters.  
 In the pool samples, bromodichloromethane was a uniquely identified 
DBP, as was 1-bromo-1-chloropropanone, and chloroacetic acid in pool 2, 3, and 
4. In general, there were more N-DBPs found in the pool water samples than 
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their corresponding tap water samples. For example, dichloroacetonitrile was 
found in every pool water sample, but was not present in tap 1 or tap 4. 
Dichloronitromethane and bromodichloronitromethane were both present in 
every pool sample, but absent from every tap water sample. Similarly, 
trichloronitromethane was detected in every pool water sample, but only found 
in tap 2. Dichloroacetamide and trichloroacetamide were both present in every 
pool sample and not present in any tap water sample. Bromochloroacetamide 
was found in pool 2 and 3, and dibromoacetamide was found in pool 3, but 
neither were found in any tap water samples. The greater presence of N-DBPs in 
the pool samples as compared to the tap water samples was not surprising 
because pools have a greater contribution of nitrogen-containing precursors from 
human inputs, such as hair, urine, sweat, skin cells, and cosmetics. 
DBPs identified in the swimming pool water formed from the reaction of the 
chlorine disinfectant with natural organic matter found in the pool. DBPs 
identified solely in the tap water samples formed from the initial reaction of 
disinfectant with natural organic matter in the drinking water plant. These 
particular chemicals potentially could have volatilized upon entering the pool 
and thereby were not also identified in the pool water. Additionally, Barcelona 
has a high amount of bromide in their source water, which causes more 
brominated DBPs in the tap water samples. By the time the tap water reaches the 
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pool facility, the bromide is likely all consumed. This, along with the chlorination 
of the pool water, and potential degradation, is a plausible explanation for why 
there are more brominated compounds in the tap samples that were not 
identified in the pool samples.  DBPs identified in both the tap and the pool 
water would need further quantification analysis to see if the quantity present in 
the pool water was the same as in the tap water, or if more had formed in the 
chlorinated pool.  
 
2.4 Conclusions 
Around 100 DBPs were comprehensively identified in tap water and pool 
water samples collected from the same pool and tap during four sampling 
campaigns in Barcelona, Spain. While the DBPs identified in the tap water 
samples and pool water samples had many similarities, there was a prevalence of 
N-DBPs in the pool water samples, likely from the increased nitrogenous organic 
input from swimmers.  
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FIGURES 
 
 
Figure 2.1: GC-MS chromatogram of tap 4, tap water sampled from Barcelona, Spain on 
December 9, 2013. 
 
 
 
 
 
Figure 2.2: GC-MS chromatogram of pool 4, pool water sampled from chlorinated indoor 
pool in Barcelona, Spain on December 9, 2013. 
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TABLES
Table 2.1: DBPs identified in pool and tap waters. “EA” denotes extracts in ethyl acetate 
and not derivatized. “DM” denotes extracts that were derivatized with diazomethane. 
 
"X" indicates that a particular DBP was identified in that sample. 
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Regulated Trihalomethanes
Bromodichloromethane  X X X X X X
Dibromochloromethane X X X X X X X X X X X X X X X X
Bromoform X X X X X X X X X X X X X X X X
Unregulated Haloalkanes
Bromomethane X X
Dibromomethane X
2,3-Dichlorooctane X X
2-Bromo-1-chloro-2-methylpropane X X X
2-Bromo-1-chloro-2-propane X
1,1-Dichloropentane X X
1,1,2-Trichloroethane X X X X X
Halonitriles
Dichloroacetonitrile X X X X X X X X X X X X X
Bromochloroacetonitrile X X X X X X X X X X X X X X X X
Dibromoacetonitrile X X X X X X X X X X X X X X X X
Tribromoacetonitrile X X X X X X X X
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Table 2.1 continued 
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Haloketones
1-Bromo-2-propanone X X X X X X X X
1-Chloropropanone X X
1,1-Dichloropropanone X X X
1,3-Dichloropropanone X
1-Bromo-1-chloropropanone X X X X X X
1,1-Dibromopropanone X X
1,1,1-Trichloropropanone X X X X X X X X X X X X X X
1,1,3-Trichloropropanone X X X X X
1-Bromo-1,1-dichloropropanone X X X X X X X X X
1,1,1-Tribromopropanone X X X X X X
1,1,1,3-Tetrachloropropanone X X X X X X X X X X X X X X
1,1,3,3-Tetrachloropropanone X X X X X X X X X X X X X X
Pentachloropropanone X X X X X X X X X X
3-Chloro-2,5-furandione X X X X X X X X X X
3,4-Dichloro-2,5-furandione X X X
1-Chloro-3,3,-dimethyl-2-butanone X X
Haloaldehydes
2,3-Dichloro-2-methylpropanal X
2-Bromo-2-methylpropanal X
Bromochloroacetaldehyde X X X X X X X X X X X X X
Bromodichloroacetaldehyde X X X X X X X X X X X X X X X X
Dibromoacetaldehyde X X X X X X X X X X X X X X X X
Dibromochloroacetaldehyde    X X X X X X X X
Dichloroacetaldehyde X X X X X X X X X X X X X X
Tribromoacetaldehyde X X X X X X X X
Trichloroacetaldehyde X X X X X X X X X
Halonitromethanes
Dichloronitromethane X X X X X X X X
Trichloronitromethane X X X X X X X X X X
Bromodichloronitromethane  X X X X X X X X
Haloamides
Dichloroacetamide X X X X X X X X
Bromochloroacetamide X X
Dibromoacetamide  X X
Trichloroacetamide X X X X X X X X
Haloacetic Acids
Chloroacetic acid X X X
Dichloroacetic acid X X X X X X X X
Bromochloroacetic acid  X X X X X X
Dibromoacetic acid  X X X X X X X X
Trichloroacetic acid X X X X X X X X
Bromodichloroacetic acid X X X X X X X X
Dibromochloroacetic acid X X X X X X X X
Tribromoacetic acid X X X X
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Table 2.1 continued. 
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Other Mono-Haloacids
2,2-Dibromopropanoic acid X X X X
2,2-Dichloropropanoic acid X X X X X X X
2,3-Dichloropropenoic acid X
2-Chloro-3-methylbutanoic acid X X X
2-Chloro-3-methylmaleic acid X X X X
Bromomaleic acid X X X X X X
cis-2,3-Dibromobutenoic acid X X X X X
Dibromomaleic acid X X X X
trans-2,3-Dibromobutenoic acid X X X X X
Trichloropropenoic acid X X X X X X
Halo-di-acids
cis-2,3-Dibromobutenedioic acid X X X X
trans-2,3-Dibromobutenedioic acid X X X X
Other Halogenated DBPs
1,1-Dichloro-1-propene X
1,2-Dichloro-1-propene X
1,2-Dichloroethanol acetate X
1-Bromo-2-methylbenzene X X X
1-Bromo-3,5-dimethylbenzene X
1-Chloro-2-ethanol acetate X X X X X X X
2,2-bis (chloromethyl)-1-propanol X
2,3-Dichloropropanol X
2,4-Dibromo-2-butyne X
2-Bromo-1,1-diethoxyethane X
2-Chloro-1, 1-diethoxyethane X X X X X
2-Chloro-1,3-butadiene X
2-Chloroethyl benzoate X X
3,3,3-Trichloropropene X
3-Chloro-1-hexene X X X X
3-Chloro-2-methyl-1-propene X X
6-Chloro-1-hexanol X
Benzyl chloride X X
Benzyl chloroformate X
Bromomethyl benzene X X X X
Dichlorophenol X
Tetrachlorobenzenamine X
Tetrachlorophenol X
Tribromophenol X X
Trichlorobenzenamine X X X X X
Trichloromethylbenzene X
Trichlorophenol X X X X X X X X
Non-Halogenated DBPs/Chemicals
Benzaldehyde X X X X X X X X X X X X X X X X
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CHAPTER 3  
IODINATED MEDICAL IMAGING COMPOUNDS AS A 
POTENTIAL PRECURSOR FOR IODINATED DISINFECTION BY-
PRODUCTS IN DRINKING WATER 
3.1 Introduction 
When chlorine is used as the disinfectant, the reaction of free chlorine with 
NOM forms chloro-DBPs. Simultaneously, the free chlorine can react with iodide 
present to rapidly form hypoiodous acid. The hypoiodous acid can then react 
with NOM to form iodo-DBPs. This reaction, however, is not as kinetically 
favored as the reaction between hypoiodous acid and free chlorine, which reacts 
to form iodite, and then further reacts with more free chlorine to form iodate. 
The iodate is a non-toxic sink for iodide. Thus, iodo-DBPs are much less 
prevalent when chlorine is used as the disinfectant (Figure 3.1).58  Conversely, 
when monochloramine is used as the disinfectant, the monochloramine will also 
react with NOM to form chloro-DBPs, but the reaction between the 
monochloramine and iodide to form hypoiodous acid is much faster. Unlike 
chlorine, monochloramine does not rapidly oxidize hypoiodous acid into iodite. 
While the reaction is thermodynamically possible, it is not kinetically favored. 
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This causes hypoiodous acid to have a longer half-life in waters that are 
disinfected with monochloramine, which gives them time to react with NOM 
and form iodo-DBPs (Figure 3.2).58 Iodo-DBPs are therefore the toxic sink for 
iodide in this reaction. Although the formation of iodo-DBPs is favored with 
monochloramine disinfection, disinfection with monochloramine generally 
produces lower levels of the regulated trihalomethanes, haloacetic acids, and 
total organic halogen when compared to free chlorine.1 Therefore, many cities are 
switching from chlorination disinfection to chloramination.1 
 A 23 city survey was conducted in the United States and Canada to 
investigate the occurrence of iodo-DBPs.1 It was found that generally, in cities 
where there was high iodide naturally present, there were high concentrations of 
iodo-DBPs. There were four cities that did not follow this trend, however, and 
despite having low or non-detectable levels of naturally occurring iodide 
present, they still had higher (µg/L) concentrations of iodo-acids and iodo-THMs 
(Table 3.1). It was surmised that there must be another source of iodine that was 
contributing to the formation of these iodo-DBPs.1 
 X-ray contrast media (ICM) are widely used to enhance the visibility of 
soft tissues within the body for medical imaging.59  They are non-toxic and after 
application, 95% of unmetabolized ICM are excreted from the body within 24 
hours.59 They are the primary contributor to the total organic halogen/adsorbable 
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organic halogens (TOX/AOX) burden in clinical wastewater and act as a large 
source of AOX in municipal wastewater.60 In fact, ICM are found in the 
environment at higher concentrations than any other pharmaceutical.60 In the 
four cities mentioned above with low naturally occurring iodide, there were high 
levels of ICM present in the waters (Table 3.2). 59 Iopamidol was present in the 
highest concentrations, suggesting that it could be a potential precursor for iodo-
DBPs. It was found that in the presence of NOM, iopamidol could act as an 
organic iodine source and react with either chlorine or chloramine to produce 
iodo-DBPs.61 Unlike iodide, however, iopamidol reacts more readily with 
chlorine, due to a different mechanism of formation.59  
Using high resolution liquid chromatography-mass spectrometry/mass 
spectrometry (LC-MS/MS) high molecular weight iodo-DBP transformation 
products from iopamidol were isolated.61-62 Genotoxicity and cytotoxicity testing 
were conducted on five of the 19 isolated high molecular weight DBPs, and it 
was found that they were not very toxic, especially in comparison to the lower 
molecular weight iodo-DBPs (Figure 3.3, Table 3.3).62 However, increased toxicity 
of water when iopamidol is present was observed (Figures 3.4 and 3.5). It is 
hypothesized that the lower molecular weight DBPs being formed with 
iopamidol are driving the toxicity and are therefore crucial to identify. Chapter 2 
focuses on research involving the role of iopamidol as a precursor to iodinated 
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DBPs, specifically with regard to the formation, identification, and quantification 
of lower molecular weight iodinated-DBPs in water from North Carolina (Cape 
Fear River), South Carolina (Broad River), and Germany (Rhine River). 
3.2  Experimental Methods 
Chemicals and Reagents. Reagents were ACS reagent grade and were 
purchased from Sigma-Aldrich (St. Louis, MO) and Fisher Scientific (Waltham, 
MA). DBP standards were purchased or custom synthesized from Sigma-
Aldrich, CanSyn Chem. Corp. (Toronto, ON), Aldlab Chemicals (Woburn, MA), 
and TCI America (Waltham, MA) at the highest level of purity. Both 1,2-
dibromopropane, internal standard, and Diazald, methylating agent for halo-
acids, were purchased from Sigma-Aldrich. All solvents (acetonitrile, hexanes, 
methyl tert-butyl ether (MTBE), methanol, and ethyl acetate) were of highest 
purity and were purchased from Sigma-Aldrich (St. Louis, MO) or VWR 
International (Radnor, PA). Figures 3.6-3.8 give a summary of all experiments 
performed on each source water. 
Comprehensive Identification Experiments. Water samples for 
comprehensive analysis were extracted using XAD resins (DAX-8 over XAD-2, 
45 mL of each for North Carolina, 30 mL of each South Carolina, Germany), 
according to a previously published procedure.57 Prior to use, new resins were 
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extensively cleaned using Soxhlet extraction.63 Table 3.4 provides reaction and 
experimental conditions for each of the three different water sources. Briefly, 
water samples were acidified to pH 1 with sulfuric acid and were poured over 
the XAD resins packed in a glass column containing glass wool at the top and 
bottom. Once the water had completely eluted, organic compounds were eluted 
with ethyl acetate (420 mL for North Carolina, 100 mL for South Carolina, 
Germany). A separatory funnel was used to remove the water layer, and 30 g of 
sodium sulfate was used to further dry the extract. Final extracts were 
concentrated using a Turbovap and a gentle stream of nitrogen to1 mL and 
spiked with 1,2-dibromopropane internal standard. Half of the final XAD resin 
extract was analyzed directly by GC-MS and the other half was derivatized with 
diazomethane for the identification of halo-acids through their corresponding 
methyl esters.55 Diazomethane was freshly generated according to a U.S. 
Environmental Protection Agency Standard Operating Procedure.64 Briefly, 
approximately 0.367 g of Diazald® and 1.0 mL of CARBITOL™ were added to 
the inner tube of an Aldrich® diazomethane-generator apparatus and 3.0 mL of 
MTBE was added to the outer portion. The apparatus was assembled, placed in 
ice, and 1.5 mL of 37% potassium hydroxide (KOH) was injected dropwise 
through the septum into the inner tube. After reacting for 1 hour, 250 μL of the 
diazomethane (dissolved in MTBE in the outer tube) was added to each 500 μL 
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sample. After 30 min of reaction, excess diazomethane in the samples was 
quenched with approximately 10 mg of silica gel. Derivatized extracts were 
transferred to new vials to remove solid silica from the samples. 
Comprehensive GC-MS analyses were performed using electron ionization 
(EI) on an Agilent 5975 inert XL Mass Selective Detector mass spectrometer 
equipped with an Agilent model 6890 GC and operated at an accelerating 
voltage of 8 kV and a source temperature of 200°C (Agilent Technologies, Santa 
Clara, CA). Injections of 1 µL of the extracts were introduced via a split/splitless 
injector (in pulsed splitless mode) onto a GC column (RTX-200, 30 m X 0.25 mm 
i.d., 0.25 µm film thickness, Restek, Bellefonte, PA). The GC temperature 
program consisted of an initial temperature of 35°C (4 min), increased to 9°C/min 
to 280°C and held for 30 minutes. The transfer line was held at 280°C and the 
inlet temperature at 250°C with an electron energy at 70 eV. Analyses were 
performed in full scan.  
Samples from North Carolina and South Carolina were also analyzed on a 
LECO GC-HRT high resolution time-of-flight mass spectrometer (St. Joseph, MI) 
operated in positive electron ionization mode at 70 eV, in high resolution (25,000) 
(full-width-at-half-maximum) with a mass range m/z 30-650, 5 spectra/s, and at a  
source temperature of 200°C. Samples were introduced with an Agilent 7693 
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autosampler with a 7890B GC equipped with a multimode inlet operated in cold 
splitless mode onto a GC column (RXi-5ms, 30 m × 0.25 mm i.d., 0.25 μm film 
thickness, Restek, Bellefonte, PA). The GC temperature program began at an 
initial temperature of 35°C (4 min), increased at 9 °C/min to 280 °C, and was held 
for 30 min. The transfer line was held at 280 °C and the injection port at 250 °C.9 
Analyses were performed in full scan.  
Mass spectra of unknown compounds were subjected to library database 
searching (using the National Institute of Standards and Technology [NIST] 
database. When there was not a sufficient library match to offer an identification, 
high resolution data, when available, was used to provide empirical formulas for 
molecular ions and fragments. Additionally, mass spectra were also subject to 
manual interpretation, where fragmentation and isotope patterns were used to 
provide tentative structural identifications. To confirm tentative identifications, 
standards were purchased or synthesized and used to compare mass spectra and 
retention times.  
North Carolina Water Reaction Conditions. For comprehensive 
identification of iodo-DBPs in North Carolina water from ICM, reactions were 
conducted by a collaborator. To summarize their research methods, 
approximately 121 L of source water from the Cape Fear River (total organic 
carbon: 2.1 ppm, [Br-/I-]: <0.5 μM) was reacted headspace free, buffered with 
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phosphate buffer to a pH of 7.5. Iopamidol was spiked at 5μM and HOCl 
(disinfectant) was spiked at a concentration of 100 μM. (Blank: North Carolina 
water with disinfectant, no iopamidol.) This light sensitive reaction was carried 
out in large barrels (with Teflon liners) for 72 hours. An example chromatogram 
obtained from North Carolina water is illustrated in Figure 3.9. 
South Carolina Water Reaction Conditions. For comprehensive 
identification of iodo-DBPs in South Carolina water from ICM, 6.5 L of source 
water from the Broad River was collected in 20L Teflon carboys and filtered once 
through Merck Millipore Glass Fibre prefilters (5 µm) and then through Merck 
Millipore Durapore Membrane filters (0.45 µm). (Prior to extraction and analysis, 
water was stored at 4°C in the dark) The water was buffered with a 10 mM 
borate buffer to a pH of 8.5. Iopamidol was added at a concentration of 1 μM and 
HOCl was added at a concentration of 12 ppm. (Blank: South Carolina water 
with iopamidol, no disinfectant). The reaction was carried out for 24 hours. An 
example chromatogram obtained from South Carolina water is illustrated in 
Figure 3.10.  
Germany Water Reaction Conditions. For comprehensive identification of 
iodo-DBPs in Germany water from ICM, 10 L of source water from the Rhine 
River was filtered through Merck Millipore Glass Fibre 5 µm prefilters and then 
through Merck Millipore Durapore Membrane 0.45 µm filters. The water was 
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then buffered with a 10 mM borate buffer to a pH of 8.5. Iopamidol was spiked at 
a concentration of 1 μM and HOCl was spiked at a concentration of 12 mg/L or 3 
mg/L. (Blank: Rhine River water with disinfectant, no iopamidol). The reaction 
was carried out for 1 hour, 4 hours, 8 hours, or 24 hours. An example 
chromatogram obtained from Germany water is illustrated in Figure 3.11.  
I-THMs Quantification Experiments. Analytical methods were created to 
measure iodo-trihalomethanes (I-THMs), a group of priority unregulated DBPs. 
Stock solutions of DBP standards were made by dissolving DBP standards in 
anhydrous acetonitrile or methanol. A calibration curve for I-THMs was made 
with the following concentrations: 0.005, 0.010, 0.025, 0.050, 0.100, 0.500, 1.00, 
2.50, 5.00, and 10.0, 20.0, 30.0, 40.0, and 50.0 μg/L.  
Analyte detection was performed using electron ionization (EI) on an Agilent 
5975 inert XL Mass Selective Detector mass spectrometer equipped with an 
Agilent model 6890 GC and operated at an accelerating voltage of 8 kV and a 
source temperature of 200°C (Santa Clara, CA), carried out in selected ion 
monitoring (SIM) mode. Table 3.5 shows selected ions (m/z values) and retention 
times selected to monitor each compound. Injections of 1 µL of the extracts were 
introduced via a split/splitless injector (in pulsed splitless mode) onto a GC 
column (RTX-200, 30 m X 0.25 mm i.d., 0.25 µm film thickness, Restek, Bellefonte, 
PA). The GC temperature program consisted of an initial temperature of 35°C (4 
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min), increased to 9°C/min to 280°C and held for 30 minutes. The transfer line 
was held at 280°C and the inlet temperature at 250°C with an electron energy at 
70 eV. Quantification ions had a dwell time of 100 ms, and qualifier ions had a 
dwell time ranging from 50 to 75 ms. Quantification ions were selected based on 
relative abundance, generally selecting the most abundant ions.  
South Carolina Water I-THMs Quantification Experiments. To measure 
volatile I-THMs in South Carolina water, a single liquid–liquid extraction (LLE) 
was performed. The water was first filtered once through Merck Millipore Glass 
Fibre prefilters (5 µm) and then through Merck Millipore Durapore Membrane 
filters (0.45 µm) and buffered to a pH of 8.5 using 10 mM borate buffer. 
Iopamidol at a concentration of 1 μM and chlorine at a concentration of 12 ppm 
were added to the water. The water was reacted headspace free in the dark for 24 
hours. After 24 hours elapsed and prior to the extraction, the amount of residual, 
unreacted chlorine was measured using the DPD (N, N-diethyl-p-
phenylenediamine) method.65. Samples were then quenched with excess ascorbic 
acid (chlorine to ascorbic acid molar ratio of 1:1.3) and adjusted to pH 3.5–4 with 
1 M sulfuric acid. Aliquots of 100 mL were spiked with 30 g of sodium sulfate 
and 2 mL of MTBE in 125 mL amber bottles. Samples were shaken for 30 min on 
a mechanical shaker, followed by a 10 min resting period to allow the organic 
phase and aqueous phase to separate. The organic phase was then removed and 
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deposited into a conical test tube. Anhydrous sodium sulfate was added to the 
extract to remove any excess water, and 250 μL was transferred with a syringe 
into a gas chromatography (GC) vial. Final extracts were spiked with internal 
standard 1,2-dibromopropane.1  
Germany Water I-THM Quantification Experiments. To measure volatile I-
THMs in Germany water, a single liquid–liquid extraction was performed. The 
water was first filtered once through Merck Millipore Glass Fibre prefilters (5 
µm) and then through Merck Millipore Durapore Membrane filters (0.45 µm) 
and buffered to a pH of 8.5 using 10 mM borate buffer. Iopamidol at a 
concentration of 1 μM and chlorine at a concentration of either 3 ppm or 12 ppm 
were spiked into the water. The water was reacted headspace free in the dark for 
different amounts of time (TABLE 3.6). After the designated period of time for 
the given experiment had elapsed and prior to the extraction, the amount of 
residual, unreacted chlorine was measured using the DPD (N, N-diethyl-p-
phenylenediamine) method.65. Samples were then quenched with excess ascorbic 
acid (chlorine to ascorbic acid molar ratio of 1:1.3) and adjusted to pH <1 with 
1 M sulfuric acid. Aliquots of 100 mL were spiked with 30 g of sodium sulfate 
and 2 mL of MTBE in 125 mL amber bottles. Samples were shaken for 30 min on 
a mechanical shaker, followed by a 10 min resting period to allow the organic 
phase and aqueous phase to separate. The organic phase was then removed and 
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deposited into a conical test tube. Anhydrous sodium sulfate was added to the 
extract to remove any excess water, and 250 μL was transferred with a syringe 
into a gas chromatography (GC) vial. Final extracts were spiked with internal 
standard 1,2-dibromopropane.1  
IAAs Quantification Experiments. Analytical methods were created to 
measure iodo-acetic acids (IAAs), a group of unregulated priority DBPs. Stock 
solutions of DBP standards were made by dissolving DBP standards in 
methanol. One calibration curve for IAAs was made with the following 
concentrations: 0.005, 0.010, 0.025, 0.050, 0.100, 0.500, 1.00, 2.50, 5.00, and 10.0, 
20.0, 30.0, 40.0, and 50.0 μg/L.  
Derivatized samples were analyzed by GC-tandem mass spectrometry 
(MS/MS) for iodoacetic acids using a Thermo TSQ-MS triple quadrupole mass 
spectrometer coupled to a TRACE GC 2000 gas chromatograph (Thermo 
Scientific, Waltham, MA). Sample volumes of 2.0 μL were injected at an inlet 
temperature of 200°C with a splitless time of 0.50 min and split flow of 
10 mL/min. GC separations were performed using an RTX-5 column 
(30 m × 0.25 mm ID × 0.25 μm film thickness; Restek Corporation, Bellefonte, 
PA), with the following oven temperature program: 35°C for 4 minutes, followed 
by a 9°C/min ramp to 280°C, and held for 20 min. The transfer line temperature 
was controlled at 200°C. An EI source was used at a temperature of 180°C, 
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emission current of 50 μA, and electron energy of 70 eV. Multiple reaction 
monitoring (MRM) was used to quantify iodocetic acid (IAA), chloroiodoacetic 
acid (CIAA), bromoiodoacetic acid (BIAA), and diiodoacetic acid (DIAA). Two 
MS–MS transitions, one quantitative and one qualitative, were used for each of 
the IAAs, along with 1,2-dibromopropane internal standard (Figure 3.12, Table 
3.7). Table 3.7 also shows the optimized collision energies for each of the iodo-
acids quantified. 
South Carolina Water IAAs Quantification Experiments. To measure 
volatile IAAs in South Carolina water, a multiple liquid–liquid extraction (LLE) 
was performed. The water was first filtered once through Merck Millipore Glass 
Fibre prefilters (5 µm) and then through Merck Millipore Durapore Membrane 
filters (0.45 µm) and buffered to a pH of 8.5 using 10 mM borate buffer. 
Iopamidol at a concentration of 1 μM and chlorine at a concentration of 12 ppm 
were spiked into the water. The water was reacted headspace free in the dark for 
24 hours. After 24 hours elapsed and prior to the extraction, the amount of 
residual, unreacted chlorine was measured using the DPD (N, N-diethyl-p-
phenylenediamine) method.65. Samples were then quenched with excess ascorbic 
acid (chlorine to ascorbic acid molar ratio of 1:1.3) and adjusted to pH <1 with 
concentrated sulfuric acid. Aliquots of 100 mL were spiked with 30 g of sodium 
sulfate and 5 mL of MTBE in 125 mL amber bottles. Samples were shaken for 
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15 min on a mechanical shaker, followed by a 10 min resting period to allow the 
organic phase and aqueous phase to separate. The organic phase was then 
removed and deposited into a conical test tube. Samples were extracted again for 
a total of three LLEs and a total of 15 mL of MTBE. The collected extract was 
passed through a sodium sulfate column to remove excess water, and 
concentrated under nitrogen to a final volume of 200 μL. Final extracts were 
derivatized using 100 μL of freshly generated diazomethane, as previously 
described.  
3.3 Results and Discussion 
North Carolina Water. Figure 3.9 shows the GC-MS chromatogram of the 
North Carolina water that was spiked with iopamidol and chlorine disinfectant. 
In this chromatogram, the m/z 126.9 peak was extracted (I+ fragment) for de-
convolution purposes. Of the peaks extracted, several were identified as iodo-
DBPs. Two new compounds, chloroiodoacetonitrile and iodoacetonitrile, that 
have never before been reported as DBPs, were found. These compounds were 
identified using their characteristic mass spectra (Figures 3.13- 3.16). Because 
they had not been reported as DBPs prior to this study, the samples were re-
analyzed on a high resolution time-of-flight GC-MS (HR-TOF-GC-MS) (Figures 
3.17 and 3.18). High resolution allows for accurate mass data to be obtained, 
which is extremely useful in identifying unknowns. The high resolution mass 
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spectrum for chloroiodoacetonitrile gave an observed m/z of 200.8836 as 
compared to the theoretical m/z of 200.8842. The m/z 200.8836 and m/z 202.8836 
peaks result from the two natural isotopes of chlorine (35Cl and 37Cl). The peak at 
m/z 126.9039 was identified as iodine, which has an exact mass of 126.9044. The 
peak at m/z 73.97910 was identified as C2HNCl+, which has an exact mass of 
73.97975. We are currently waiting for a standard of chloroiodoacetonitrile to be 
synthesized for confirmation. The iodoacetonitrile peak was confirmed using a 
standard and the mass spectra was also compared to a library spectra for 
additional support. The observed m/z from the high resolution spectra was m/z 
166.9226 as compared to the theoretical mass of m/z 166.9232. 
Also present in the North Carolina water chromatogram was a peak 
identified as iodoacetic acid. Usually, halo-acids are not seen in the 
underivatized samples. They usually exist at too low of concentrations to be 
detected without derivatization. However, in this sample, the concentration was 
high enough where it could be identified in its underivatized form. This is 
significant because iodoacetic acid is the most toxic DBP known to date (Figure 
3.19). The toxicity of iodoacetonitrile had been studied prior to this experiment. 
While it is not as toxic as iodoacetic acid, it is more toxic than the known animal 
carcinogen, 3-chloro-4-(dichloromethyl)-5-hydroxy-5H-furan-2-one , more 
commonly known as Mutagen X (MX). 27 Because there is not currently a 
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standard for chloroiodoacetonitrile, the toxicity is unknown. However, the 
toxicity is predicted to be similar to that of iodoacetonitrile.  
Using a new highly sensitive GC-MS/MS method, several new tri-halo 
acids were detected in the North Carolina waters. This method has low ppt 
detection levels, achieved through multiple reaction monitoring of predicted 
fragmentations for the compounds (Figure 3.12). Currently, we are waiting for 
standards of the tri-halo acids to be synthesized for confirmation. 
South Carolina Water. Figure 3.10 shows the GC-MS chromatogram of 
the South Carolina water that was spiked with iopamidol and chlorine 
disinfectant.  In this chromatogram, the m/z 126.9 peak was once again extracted. 
The two new compounds, chloroiodoacetonitrile and iodoacetonitrile, found in 
the iopamidol reactions with North Carolina waters were also identified in these 
reactions. Iodoacetic acid was also present again in its underivatized form.  
Several I-THMs were quantified in the South Carolina water that was 
reacted with iopamidol and chlorine for 24 hours. Dichloroiodomethane was 
found at a concentration of 2.9 ± 0.22 µg/L, bromochloroiodomethane was found 
at a concentration of 0.38 ± 0.0091 µg/L, dibromoiodomethane was found at a 
concentration of 0.38 ± 0.0011 µg/L, and chlorodiiodomethane was found at a 
concentration of 0.56 ± 0.00042 µg/L (Figure 3.20). None of these compounds 
were found at detectable concentrations in the blank (South Carolina water 
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reacted with chlorine disinfectant, no iopamidol), suggesting they are the 
byproduct of the reaction between iopamidol and chlorine.  
Several iodo-acids were formed in the South Carolina water after the 24 
hour reaction of iopamidol with chlorine disinfectant. Iodoacetic acid was 
present at 131.2 ± 50.3 ng/L, chloroiodoacetic acid was present at 144.8± 42.5 ng/L, 
and diiodoacetic acid was present at 4.2 ± 1.7 ng/L. None of these acids were 
present at detectable concentrations in the blank (South Carolina water reacted 
with chlorine, no iopamidol), suggesting that they are formed in the reaction 
between iopamidol and chlorine (Figure 3.21). 
Germany Water. Figure 3.11 shows an example GC-MS chromatogram of 
Rhine River water from Germany spiked with iopamidol and chlorine 
disinfectant with the m/z 126.9 peak extracted. No iodo-THMs or iodo-acids were 
identified in this analysis using GC-MS will full-scan. This is likely because the 
levels detected were too low to be observed in a full scan analysis. Several I-
THMs were observed and quantified by the instrument analyzing in SIM mode, 
which is a more sensitive method of analysis. 
Dichloroiodomethane, bromochloroiodomethane, and 
dibromoiodomethane were found to form when Rhine River water was reacted 
with iopamidol and chlorine in various timed reactions (Figures 3.22-3.24). 
Levels for chlorodiiodomethane (CDIM), iodoacetonitrile (IAN), 
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bromodiiodomethane (BDIM), and triiodomethane (TIM), were non-detect for all 
time points. Specifically, dichloroiodomethane (DCIM) was quantified in the 
water that was reacted with iopamidol and 3 mg/L of chlorine for just ten 
minutes at a concentration of 0.470 ± 0.0035 µg/L. It was quantified in every 
subsequent reaction of iopamidol with 3 mg/L of chlorine, with a maximum 
concentration of 0.83 ± 0.0063 µg/L for the 24 hour reaction (Figure 3.22). DCIM 
was also measured at a level of 0.61 ± 0.064 µg/L in the water reacted with 12 
mg/L of chlorine and iopamidol for 24 hours. The concentration of DCIM formed 
was less with 12 mg/L of chlorine, and it also took significantly longer for DCIM 
to form at this concentration of disinfectant. This is potentially because the excess 
chlorine inhibits the formation of DBPs. Most DBPs formed from chlorine 
disinfectant are formed through oxidation and substitution reactions. These 
reactions proceed much more rapidly at high pH than low pH.66 In the water 
spiked with 12 mg/L of chlorine, the higher concentration of chlorine is achieved 
by adding more hypochlorous acid. The increased concentration of acid lowers 
the pH, which can slow the reactions that form I-THMs. Thus, higher 
concentrations of I-THMs are observed when the waters were spiked with 3 
mg/L of chlorine over 12 mg/L of chlorine.  
Bromochloroiodomethane (BCIM) was also quantified in several samples 
of Rhine River water reacted with iopamidol and chlorine. It was first observed 
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in the sample reacted for 30 minutes, at a concentration of 0.44 ± 0.0012 µg/L and 
observed in every subsequent sample spiked with 3 mg/L of chlorine (Figure 
3.23). The greatest concentration was observed in the sample reacted for 24 
hours. BCIM was also formed after 8 hours in the sample spiked with 12 mg/L of 
chlorine at a concentration of 0.45 ± 0.0091 µg/L and in the sample spiked with 12 
mg/L of chlorine and reacted for 24 hours at a concentration of 0.45 ± 0.015 µg/L. 
The trend of increased formation with 3 mg/L of chlorine as compared to 12 
mg/L of chlorine was observed.  
Lastly, dibromoiodomethane (DBIM) was quantified in two samples; it 
was quantified in the sample reacted for 20 hours at a concentration of 0.35 ± 
0.00064 µg/L, and in the sample reacted for 24 hours at a concentration of 0.35 ± 
0.00071 µg/L (Figure 3.24). This limited data suggests that somewhere between 8 
and 20 hours dibromoiodomethane is formed from the reaction of iopamidol and 
chlorine in Rhine River water. The maximum concentration is reached no later 
than 20 hours, as seen by the similar concentrations observed at both 20 and 24 
hours. Again, the trend of increased formation with a lower concentration of 
disinfectant was observed. 
Because none of the I-THMs were present in the water reacted for 0 
minutes, it can be concluded that all of the I-THMs found were formed from the 
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reaction of iopamidol with disinfectant and natural organic matter in the water 
from Germany. 
In the Germany water experiments to quantify I-THMs, water was found 
present in the MTBE extracts. Because not all of the water was removed in the 
extraction, these experiments should be repeated for more reliable 
quantifications. 
3.4 Conclusions 
It is important to identify and quantify iodo-DBPs because they are the 
most toxic class of DBPs and none of them are currently regulated. There are low 
MW iodo-DBPs formed from the reaction of iopamidol with natural organic 
matter and disinfectant. Some of these low MW iodo-DBPS, such as iodoacetic 
acid, are already known to be toxic. This supports the hypothesis that lower MW 
iodo-DBPS are contributing to the increase in toxicity when iopamidol is present 
in the water. It can be concluded that X-ray contrast media are able to serve as 
iodinated precursors in the formation of toxic iodo-DBPs. 
 This work comprehensively identified fifteen different iodo-DBPs in three 
different source waters from North Carolina, South Carolina, and Germany that 
were reacted with iopamidol and chlorine disinfectant (Table 3.8). Several of 
these iodo-DBPs were found for the first time. A new GC-MS/MS method was 
used to identify some of these iodo-DBPs because it has low ppt detection levels 
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and is therefore very sensitive. Several I-THMs were quantified at low µg/L 
(ppb) levels after having formed in South Carolina water reacted with iopamidol 
and chlorine for 24 hours. Additionally, several iodoacetic acids were also 
quantified in this water at low ppt levels. In the water from Germany, it was 
found that In general, higher levels of I-THMs were formed in waters spiked 
with 3 mg/L of chlorine vs. waters spiked with 12 mg/L of chlorine. This was 
attributed to the increased pH when 12 mg/L of chlorine was spiked, slowing 
down the formation of I-THMs. Higher concentrations were generally found in 
waters that had been reacted the longest. All concentrations were found to be 
low µg/L levels. 
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FIGURES 
 
 
 
Figure 3.1: Formation of DBPs when chlorine is used as the disinfectant.58 
 
 
 
 
Figure 3.2: Formation of DBPs when monochloramine is used as the disinfectant.58 
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Figure 3.3: Cytotoxicity of high MW iopamidol transformation product iodo-DBPs. 
Note: None were genotoxic.61 
 
 
Figure3.4: Increased genotoxicity when iopamidol is present. 
Akron SW+ 
Akron SW+ 
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Figure 3.5: Increased cytotoxicity when iopamidol is present. 
Akron SW+ 
Akron SW+ 
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Figure 3.6: Summary of experiments performed on North Carolina river water from the 
Cape Fear River. 
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Figure 3.7: Summary of experiments performed on South Carolina river water from the 
Broad River. 
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Figure 3.8: Summary of experiments performed on Germany river water from the Rhine 
River. 
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Figure 3.10: GC chromatogram of South Carolina river water with iodo-DBPs identified. 
m/z 126.9 extracted. 
 
Figure 3.11: GC chromatogram of Germany river water with iodo-DBPs identified. m/z 
126.9 extracted. 
Figure 3.9: GC chromatogram of North Carolina river water with iodo-DBPs identified. 
m/z 126.9 extracted. 
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Figure 3.12: MRM transitions for IAAs quantified and tentatively identified new trihalo-
IAAs. 
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Figure 3.13: Low resolution mass spectrum of iodoacetonitrile.  
 
 
Figure 3.14: Structure and mass fragments of iodoacetonitrile. 
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Figure 3.15: Low resolution mass spectrum of chloroiodoacetonitrile. 
 
 
Figure 3.16: Structure and mass fragments of chloroiodoacetonitrile. 
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Figure 3.17: High resolution mass spectrum of iodoacetonitrile with library match. 
 
 
 
 
Figure 3.18: High resolution mass spectrum of chloroiodoacetonitrile. 
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Figure 3.19: Genotoxicity of DBPs by class. Iodoacetonitrile highlighted.67 
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Figure 3.20: Concentrations of iodo-THMs in South Carolina river water reacted with 
iopamidol and chlorine. 
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Figure 3.21: Concentrations of iodo-acids in South Carolina river water reacted with 
iopamidol and chlorine. 
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Figure 3.22: Concentrations of DCIM for various timed reactions of iopamidol and 
chlorine in Germany river water. 
0 0 0 0 0 0 0
0.47
0 0
0.51
0 0
0.49
0 0
0.52
0 0
0.60
0 0
0.55
0 0
0.76
0
0.48
0.83
0.61
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
0 
m
in
-B
la
n
k
0 
m
in
-3
 m
g
/L
 H
O
C
l
0 
m
in
 -
 1
2 
m
g
/L
 H
O
C
l
5 
m
in
 -
 B
la
n
k
5 
m
in
 -
 3
 m
g
/L
 H
O
C
l
5 
m
in
  -
 1
2 
m
g
/L
 H
O
C
l
10
 m
in
 -
 B
la
n
k
10
 m
in
 -
 3
 m
g
/L
 H
O
C
l
10
 m
in
 -
12
 m
g
/L
 H
O
C
l
30
 m
in
 -
 B
la
n
k
30
 m
in
 -
 3
 m
g
/L
 H
O
C
l
30
 m
in
 -
12
 m
g
/L
 H
O
C
l
1 
h
r 
- 
B
la
n
k
1 
h
r 
- 
3 
m
g
/L
 H
O
C
l
1 
h
r 
- 
12
 m
g
/L
 H
O
C
l
2 
h
r 
- 
B
la
n
k
2 
h
r 
- 
3 
m
g
/L
 H
O
C
l
2 
h
r 
- 
12
 m
g
/L
 H
O
C
l
4 
h
r 
- 
B
la
n
k
4 
h
r 
- 
3 
m
g
/ 
L
 H
O
C
l
4 
h
r 
- 
12
 m
g
/L
 H
O
C
l
8 
h
r-
 B
la
n
k
8 
h
r 
- 
3 
m
g
/L
 H
O
C
l
8 
h
r 
- 
12
 m
g
/L
 H
O
C
l
20
 h
r 
- 
B
la
n
k
20
 h
r 
- 
3 
m
g
/L
 H
O
C
l
20
 h
r 
- 
12
 m
g
/L
 H
O
C
l
24
 h
r-
 B
la
n
k
24
 h
r-
 3
 m
g
/L
 H
O
C
l
24
 h
r-
 1
2 
m
g
/L
 H
O
C
l
A
v
er
ag
e 
C
o
n
ce
n
tr
at
io
n
  
o
f 
D
u
p
li
ca
te
s 
(µ
g
/L
)
 51 
 
 
 
 
 
 
Figure 3.23: Concentrations of BCIM for various times reactions of iopamidol and 
chlorine in Germany river water. 
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Figure 3.24: Concentrations of DBIM for various timed reactions of iopamidol and 
chlorine in Germany river water.  
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TABLES 
 
 
Table 3.1: Four cities in the 23-city occurrence study with low levels of naturally 
occurring iodide, but high levels of iodo-DBPs.1 
 
 
Iodide 
Naturally 
Present (µg/L) 
 Iodo-Acids 
(µg/L) 
 Iodo-THMs 
(μg/L) 
City 2 1.0 0.37 4.9 
City 4 ND 0.10 1.2 
City 11 1.5 0.21 2.3 
City 15 ND 0.17 2.4 
 
 
Table 3.1: Concentrations (ppt) of ICM in four cities of 23-city occurrence study.59  
 Iopamidol Iomeprol Iopromide Iohexol Diatrizoate 
City 
2 
510 ND 24 120 93 
City 
4 
110 ND 6 49 ND 
City 
11 
100 ND ND 85 ND 
City 
15 
2700 ND 25 ND ND 
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Table 2.3: Mammalian cell toxicity of high molecular weight iodo-DBPs vs. low 
molecular weight iodo-DBPs. 
High 
Molecular 
Weight 
DBPs 
LC50 
(μM) 
Low Molecular Weight 
DBPs 
LC50 
(μM) 
DBP705 1441 Iodoacetic Acid 2.95 
DBP735 934 Diiodoacetic Acid 332 
DBP51 832 Bromoiodoacetic Acid 897 
DBP643 1296 Iodoform 66 
DBP778 Not 
Toxic 
Dibromoiodomethane 4130 
  Dichloroiodomethane 4130 
  Bromochloroiodomethane 2400 
  Chlorodiiodomethane 2410 
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Table 3.3: Reaction conditions for North Carolina, South Carolina, and Germany river 
waters. 
 
North Carolina 
Reaction 
Conditions 
South 
Carolina 
Reaction 
Conditions 
Germany 
Reaction 
Conditions 
Volume 121 L 6.5  L 10 L 
Buffer KH2PO4/KH3HP
O4 
10 µM 
Borate 
10 µM 
Borate 
10 µM 
pH 7.5 8.5 8.5 
[Iopamidol] 5 µM 1 µM 1 µM 
[Cl2] 100 µM 12 ppm 12 ppm 
Reaction 
Time 
72 Hours 24 Hours 1 Hour 
4 Hours 
8 Hours 
24 Hours 
XAD 
 
45 mL XAD2 
45 mL XAD 8 
420 mL of Ethyl 
Acetate Eluted 
30 mL XAD2 
30 mL XAD 8 
200 mL of 
Ethyl Acetate 
Eluted 
30 mL XAD2 
30 mL XAD 8 
200 mL of 
Ethyl Acetate 
Eluted 
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Table 3.4: Selected ions and retention times on RTx-200 column for SIM acquisition 
mode of some target iodo-DBPs. 
DBP RTx-200 SIM 
(mins) 
Major Ions 
(m/z) 
DCIM 8.308 83/85/126.9 
DBP (Internal 
Standard) 
10.601 121/123 
BCIM 10.613 126.9/128.9 
DBIM 12.704 172.8/299.7 
CDIM 13.256 174.9/302 
IAN 14.035 167/126.9 
BDIM 15.574 218.8/220.8 
TIM 18.853 266.8/393.7 
 
 
 
Table 3.5: Summary of timed I-THM quantification experiments of Germany water. 
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Table 3.6: Segment times, transitions, and optimized collision energies for some iodo-
acids. 
 
 
 
Segment Compound Time 
Transitions 
(m/z) 
Collision 
Energy 
1 
1,2-
Dibromopropane 
(Internal 
Standard) 
8 
mins 
121  41 9 eV 
123  41 9 eV 
2 
Iodoacetic acid 
methyl ester 
8-
10.5 
mins 
200 73 8 eV 
169  141 8 eV 
3 
Chloroiodoacetic 
acid methyl ester 
10.5-
12.5 
mins 
234107 4 eV 
23479 12 eV 
4 
Bromoiodoacetic 
acid methyl ester 
12.5-
14 
mins 
278  151 6 eV 
278  123 12 eV 
5 
Diiodoacetic acid 
methyl ester 
14-20 
mins 
326  199 6 eV 
326  171 12 eV 
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Table3.7: Summary of iodo-DBPs found in reacted waters. 
Iodo-THMs Iodo-Nitriles Iodo-Acids 
Dibromoiodomethane Chloroiodoacetonitrile Bromochloroiodoacetic 
Acid 
Dichloroiodomethane Iodoacetonitrile Bromoiodoacetic Acid 
Bromochloroiodomethane  Chlorodiiodoacetic Acid 
Trichloroiodomethane  Chloroiodoacetic Acid 
Chlorodiiodomethane  Dichloroiodoacetic Acid 
Iodoform  Diiodoacetic Acid 
  Iodoacetic Acid 
 59 
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